These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3923959)

  • 1. The influence of cyclo-oxygenase inhibitors on the cardiovascular effects of hydralazine in rats.
    Vidrio H; Garcia-Marquez F
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):131-41. PubMed ID: 3923959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.
    Rubin LJ; Lazar JD
    J Clin Invest; 1981 Jan; 67(1):193-200. PubMed ID: 7451649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal by hypothermia of vasodilator-induced tachycardia in anesthetized rats.
    Vidrio H; García-Márquez F
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):217-28. PubMed ID: 3675083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
    Panzenbeck M; Baez A; Kaley G
    J Pharmacol Exp Ther; 1986 May; 237(2):525-8. PubMed ID: 3084759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the sympatho-adrenal system in the reflex tachycardia produced by hydralazine in the anesthetized rat.
    Vidrio H; García-Márquez F
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):94-104. PubMed ID: 3099672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of renal prostaglandins in sympathetically mediated renin relase in the rat.
    Campbell WB; Graham RM; Jackson EK
    J Clin Invest; 1979 Aug; 64(2):448-56. PubMed ID: 37256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system.
    Maekawa K; Liang CS; Tsui A; Chen BT; Kawashima S
    Circulation; 1984 Nov; 70(5):908-16. PubMed ID: 6488504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of adrenergic nervous and prostaglandin systems on hydralazine-induced renin release.
    Sinaiko AR
    Life Sci; 1983 Dec; 33(23):2269-75. PubMed ID: 6316059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin gene-related peptide release in endotoxicosis may be mediated by prostaglandins.
    Wang X; Han C; Jones SB; Yang L; Fiscus RR
    Shock; 1995 Jan; 3(1):34-9. PubMed ID: 7850577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydralazine on adrenal and cardiac sympathetic nerve activity in anesthetized rats.
    Yoshioka M; Togashi H; Minami M; Saito H
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):313-20. PubMed ID: 3797810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats.
    Ruffolo RR; Kurz K; Paget CJ
    J Pharmacol Exp Ther; 1985 Jan; 232(1):134-8. PubMed ID: 3838104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of cardiovascular responses to hydralazine by diverse hydrazine derivatives.
    Vidrio H
    J Pharmacol Exp Ther; 1994 Oct; 271(1):171-5. PubMed ID: 7965711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydralazine inhibits vascular reactivity by a mechanism independent of vascular prostaglandin biosynthesis: role of thromboxane synthetase in blocking hydralazine actions.
    Ally AI; Horrobin DF
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):39-63. PubMed ID: 3462852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central cardiovascular and thermal effects of prostaglandin E2 in rats.
    Sirén AL
    Acta Physiol Scand; 1982 Nov; 116(3):229-34. PubMed ID: 6963085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
    Trimarco B; Cuocolo A; Ricciardelli B; Patrignani P; Volpe M; de Luca N; Condorelli M
    J Pharmacol Exp Ther; 1986 May; 237(2):589-99. PubMed ID: 3084760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostaglandin synthesis inhibition on the central activity of noradrenaline in rats.
    Brus R; Herman ZS; Sokoła A; Zielińska B
    Acta Physiol Pol; 1981; 32(1):47-51. PubMed ID: 7246205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.